| Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between … PL Lakatos, PA Golovics, G David, T Pandur, Z Erdelyi, A Horvath, ... Official journal of the American College of Gastroenterology| ACG 107 (4 …, 2012 | 242 | 2012 |
| IBD in the elderly population: results from a population-based study in Western Hungary, 1977–2008 PL Lakatos, G David, T Pandur, Z Erdelyi, G Mester, M Balogh, I Szipocs, ... Journal of Crohn's and Colitis 5 (1), 5-13, 2011 | 205 | 2011 |
| Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in … LS Kiss, T Szamosi, T Molnar, P Miheller, L Lakatos, A Vincze, K Palatka, ... Alimentary pharmacology & therapeutics 34 (8), 911-922, 2011 | 189 | 2011 |
| Is current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohort PL Lakatos, Z Vegh, BD Lovasz, G David, T Pandur, Z Erdelyi, I Szita, ... Inflammatory bowel diseases 19 (5), 1010-1017, 2013 | 130 | 2013 |
| Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohn's disease PL Lakatos, LS Kiss, K Palatka, I Altorjay, P Antal-Szalmas, E Palyu, ... Inflammatory bowel diseases 17 (3), 767-777, 2011 | 98 | 2011 |
| Treatment of extraintestinal manifestations in inflammatory bowel disease PL Lakatos, L Lakatos, LS Kiss, L Peyrin-Biroulet, A Schoepfer, ... Digestion 86 (Suppl. 1), 28-35, 2012 | 85 | 2012 |
| Evolution of disease phenotype in adult and pediatric onset Crohn’s disease in a population-based cohort BD Lovasz, L Lakatos, A Horvath, I Szita, T Pandur, M Mandel, Z Vegh, ... World Journal of Gastroenterology: WJG 19 (14), 2217, 2013 | 78 | 2013 |
| Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease PL Lakatos, Z Czegledi, G David, Z Kispal, LS Kiss, K Palatka, T Kristof, ... Journal of Crohn's and Colitis 4 (3), 283-290, 2010 | 60 | 2010 |
| Anti-TNF trough levels and detection of antibodies to anti-TNF in inflammatory bowel disease: are they ready for everyday clinical use? P Miheller, LS Kiss, K Lorinczy, PL Lakatos Expert opinion on biological therapy 12 (2), 179-192, 2012 | 41 | 2012 |
| The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: results from a population-based cohort in Eastern Europe PL Lakatos, BD Lovasz, G David, T Pandur, Z Erdelyi, G Mester, M Balogh, ... Journal of Crohn's and Colitis 7 (5), 385-391, 2013 | 35 | 2013 |
| Is the disease course predictable in inflammatory bowel diseases? PL Lakatos, LS Kiss World Journal of Gastroenterology: WJG 16 (21), 2591, 2010 | 34 | 2010 |
| Recommendations for identifying Crohn’s disease patients with poor prognosis P Miheller, LS Kiss, M Juhasz, M Mandel, PL Lakatos Expert Review of Clinical Immunology 9 (1), 65-76, 2013 | 30 | 2013 |
| NKX2-3 and IRGM variants are associated with disease susceptibility to IBD in Eastern European patients N Meggyesi, LS Kiss, M Koszarska, M Bortlik, D Duricova, L Lakatos, ... World Journal of Gastroenterology: WJG 16 (41), 5233, 2010 | 29 | 2010 |
| Risk of colorectal cancer and small bowel adenocarcinoma in Crohn's disease: a population-based study from western Hungary 1977–2008 PL Lakatos, G David, T Pandur, Z Erdelyi, G Mester, M Balogh, I Szipocs, ... Journal of Crohn's and Colitis 5 (2), 122-128, 2011 | 28 | 2011 |
| Current status of thiopurine analogues in the treatment in Crohn's disease PL Lakatos, LS Kiss World Journal of Gastroenterology: WJG 17 (39), 4372, 2011 | 14 | 2011 |
| Nutritional influences in selected gastrointestinal diseases PL Lakatos, LS Kiss, P Miheller Digestive Diseases 29 (2), 154-165, 2011 | 14 | 2011 |
| Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease L Lakatos, Z Czeglédi, G Dávid, Z Kispál, LS Kiss, K Palatka, T Kristóf, ... Orvosi hetilap 151 (7), 250-258, 2010 | 5 | 2010 |
| Low risk of lymphoma in inflammatory bowel diseases in western Hungary. Results from a population-based incident cohort P Lakatos, B Lovász, Á Horváth, T Pandur, Z Erdélyi, G Mester, M Balogh, ... Zeitschrift für Gastroenterologie 50 (05), A43, 2012 | 3 | 2012 |
| Low risk of lymphoma in inflammatory bowel diseases in western Hungary. Results from a population-based incident cohort P Lakatos, B Lovász, Á Horváth, T Pandur, Z Erdélyi, G Mester, M Balogh, ... Zeitschrift für Gastroenterologie 50 (05), A43, 2012 | 3 | 2012 |
| A korai immunszuppresszív kezelés hatása a reszekciós műtétek arányára Crohn-betegekben, Veszprém megyében, populációs alapú kohorszvizsgálat alapján= The Effect of Early … PA Golovics, PL Lakatos, G Dávid, T Pandur, Z Erdélyi, Á Horváth, ... ORVOSI HETILAP 153 (14), 541-552, 2012 | 2 | 2012 |
Peter Laszlo LakatosMcGill University and Semmelweis UniversityE-mail megerősítve itt: med.semmelweis-univ.hu
